These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Risks of Testosterone for Postmenopausal Women. Pinkerton JV; Blackman I; Conner EA; Kaunitz AM Endocrinol Metab Clin North Am; 2021 Mar; 50(1):139-150. PubMed ID: 33518182 [TBL] [Abstract][Full Text] [Related]
66. Androgens in women. Davison SL; Davis SR J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):363-6. PubMed ID: 12943723 [TBL] [Abstract][Full Text] [Related]
67. Testosterone influences libido and well being in women. Davis SR; Tran J Trends Endocrinol Metab; 2001; 12(1):33-7. PubMed ID: 11137039 [TBL] [Abstract][Full Text] [Related]
68. Clinical evaluation of women presenting with low libido and determination of whether androgen therapy might be appropriate. Papalia MA; Burger H Semin Reprod Med; 2006 Apr; 24(2):86-96. PubMed ID: 16633982 [TBL] [Abstract][Full Text] [Related]
69. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years with no complaints of sexual dysfunction. Guay A; Munarriz R; Jacobson J; Talakoub L; Traish A; Quirk F; Goldstein I; Spark R Int J Impot Res; 2004 Apr; 16(2):112-20. PubMed ID: 14999217 [TBL] [Abstract][Full Text] [Related]
70. [Testosterone therapy in female hypoactive sexual desire disorder]. Meyer P Rev Med Suisse; 2016 Mar; 12(510):540-3. PubMed ID: 27149714 [TBL] [Abstract][Full Text] [Related]
71. Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens. Cappelletti M; Wallen K Horm Behav; 2016 Feb; 78():178-93. PubMed ID: 26589379 [TBL] [Abstract][Full Text] [Related]
72. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R Menopause; 2006; 13(5):770-9. PubMed ID: 16932240 [TBL] [Abstract][Full Text] [Related]
73. Testosterone patches for female sexual dysfunction. Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838 [TBL] [Abstract][Full Text] [Related]
75. Androgen status in healthy premenopausal women with loss of libido. Nyunt A; Stephen G; Gibbin J; Durgan L; Fielding AM; Wheeler M; Price DE J Sex Marital Ther; 2005; 31(1):73-80. PubMed ID: 15841707 [TBL] [Abstract][Full Text] [Related]
78. Sexual desire, sexual arousal and hormonal differences in premenopausal US and Dutch women with and without low sexual desire. Heiman JR; Rupp H; Janssen E; Newhouse SK; Brauer M; Laan E Horm Behav; 2011 May; 59(5):772-9. PubMed ID: 21514299 [TBL] [Abstract][Full Text] [Related]
79. A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women. Jayasena CN; Alkaabi FM; Liebers CS; Handley T; Franks S; Dhillo WS Clin Endocrinol (Oxf); 2019 Mar; 90(3):391-414. PubMed ID: 30488972 [TBL] [Abstract][Full Text] [Related]
80. Opinion Paper: On the Diagnosis/Classification of Sexual Arousal Concerns in Women. Althof SE; Meston CM; Perelman MA; Handy AB; Kilimnik CD; Stanton AM J Sex Med; 2017 Nov; 14(11):1365-1371. PubMed ID: 28958593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]